Global Gastrointestinal Stromal Tumor Treatment Market 2025 by Company, Regions, Type and Application, Forecast to 2031
According to our latest research, the global Gastrointestinal Stromal Tumor Treatment market size will reach USD million in 2031, growing at a CAGR of %over the analysis period.
This report is a detailed and comprehensive analysis for global Gastrointestinal Stromal Tumor Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastrointestinal Stromal Tumor Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastrointestinal Stromal Tumor Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun Melsungen, Aohua Endoscopy, Olympus, Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Fortimedix Surgical, Cook Medical, Actavis Generics, Dr. Reddy's Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gastrointestinal Stromal Tumor Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Stromal Tumor Treatment, with revenue, gross margin, and global market share of Gastrointestinal Stromal Tumor Treatment from 2020 to 2025.
Chapter 3, the Gastrointestinal Stromal Tumor Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gastrointestinal Stromal Tumor Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumor Treatment.
Chapter 13, to describe Gastrointestinal Stromal Tumor Treatment research findings and conclusion.
This report is a detailed and comprehensive analysis for global Gastrointestinal Stromal Tumor Treatment market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
Global Gastrointestinal Stromal Tumor Treatment market shares of main players, in revenue ($ Million), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Gastrointestinal Stromal Tumor Treatment
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Gastrointestinal Stromal Tumor Treatment market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include B. Braun Melsungen, Aohua Endoscopy, Olympus, Novartis, Bayer Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Fortimedix Surgical, Cook Medical, Actavis Generics, Dr. Reddy's Laboratories, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Gastrointestinal Stromal Tumor Treatment market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Drugs
- Surgery Equipment
- Others
- Hospital
- Clinic
- Pharmacy
- Others
- B. Braun Melsungen
- Aohua Endoscopy
- Olympus
- Novartis
- Bayer Pharmaceuticals
- Glenmark Pharmaceuticals Ltd.
- Fortimedix Surgical
- Cook Medical
- Actavis Generics
- Dr. Reddy's Laboratories
- Teva Pharmaceutical Industries Ltd.
- Sonoscape
- Huger endoscopy instruments
- Bulat Pharmaceutical
- MSN Laboratories
- Apotex Inc.
- Boston Scientific
- Arthrex
- Johnson & Johnson
- CSPC Pharmaceuticals
- Hansoh Pharmaceuticals
- Kelun Pharmaceuticals
- Zai Lab
- CStone Pharmaceuticals
- China Biopharmaceuticals
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Gastrointestinal Stromal Tumor Treatment product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Gastrointestinal Stromal Tumor Treatment, with revenue, gross margin, and global market share of Gastrointestinal Stromal Tumor Treatment from 2020 to 2025.
Chapter 3, the Gastrointestinal Stromal Tumor Treatment competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Gastrointestinal Stromal Tumor Treatment market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Gastrointestinal Stromal Tumor Treatment.
Chapter 13, to describe Gastrointestinal Stromal Tumor Treatment research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastrointestinal Stromal Tumor Treatment by Type
1.3.1 Overview: Global Gastrointestinal Stromal Tumor Treatment Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type in 2024
1.3.3 Drugs
1.3.4 Surgery Equipment
1.3.5 Others
1.4 Global Gastrointestinal Stromal Tumor Treatment Market by Application
1.4.1 Overview: Global Gastrointestinal Stromal Tumor Treatment Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.4.5 Others
1.5 Global Gastrointestinal Stromal Tumor Treatment Market Size & Forecast
1.6 Global Gastrointestinal Stromal Tumor Treatment Market Size and Forecast by Region
1.6.1 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region, (2020-2031)
1.6.3 North America Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.4 Europe Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.6 South America Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 B. Braun Melsungen
2.1.1 B. Braun Melsungen Details
2.1.2 B. Braun Melsungen Major Business
2.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.1.4 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 B. Braun Melsungen Recent Developments and Future Plans
2.2 Aohua Endoscopy
2.2.1 Aohua Endoscopy Details
2.2.2 Aohua Endoscopy Major Business
2.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.2.4 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aohua Endoscopy Recent Developments and Future Plans
2.3 Olympus
2.3.1 Olympus Details
2.3.2 Olympus Major Business
2.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.3.4 Olympus Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Olympus Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.4.4 Novartis Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Bayer Pharmaceuticals
2.5.1 Bayer Pharmaceuticals Details
2.5.2 Bayer Pharmaceuticals Major Business
2.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.5.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Bayer Pharmaceuticals Recent Developments and Future Plans
2.6 Glenmark Pharmaceuticals Ltd.
2.6.1 Glenmark Pharmaceuticals Ltd. Details
2.6.2 Glenmark Pharmaceuticals Ltd. Major Business
2.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.6.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments and Future Plans
2.7 Fortimedix Surgical
2.7.1 Fortimedix Surgical Details
2.7.2 Fortimedix Surgical Major Business
2.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.7.4 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Fortimedix Surgical Recent Developments and Future Plans
2.8 Cook Medical
2.8.1 Cook Medical Details
2.8.2 Cook Medical Major Business
2.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.8.4 Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Cook Medical Recent Developments and Future Plans
2.9 Actavis Generics
2.9.1 Actavis Generics Details
2.9.2 Actavis Generics Major Business
2.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.9.4 Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Actavis Generics Recent Developments and Future Plans
2.10 Dr. Reddy's Laboratories
2.10.1 Dr. Reddy's Laboratories Details
2.10.2 Dr. Reddy's Laboratories Major Business
2.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.10.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
2.11 Teva Pharmaceutical Industries Ltd.
2.11.1 Teva Pharmaceutical Industries Ltd. Details
2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
2.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.11.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.12 Sonoscape
2.12.1 Sonoscape Details
2.12.2 Sonoscape Major Business
2.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.12.4 Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Sonoscape Recent Developments and Future Plans
2.13 Huger endoscopy instruments
2.13.1 Huger endoscopy instruments Details
2.13.2 Huger endoscopy instruments Major Business
2.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.13.4 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Huger endoscopy instruments Recent Developments and Future Plans
2.14 Bulat Pharmaceutical
2.14.1 Bulat Pharmaceutical Details
2.14.2 Bulat Pharmaceutical Major Business
2.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.14.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Bulat Pharmaceutical Recent Developments and Future Plans
2.15 MSN Laboratories
2.15.1 MSN Laboratories Details
2.15.2 MSN Laboratories Major Business
2.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.15.4 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 MSN Laboratories Recent Developments and Future Plans
2.16 Apotex Inc.
2.16.1 Apotex Inc. Details
2.16.2 Apotex Inc. Major Business
2.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.16.4 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Apotex Inc. Recent Developments and Future Plans
2.17 Boston Scientific
2.17.1 Boston Scientific Details
2.17.2 Boston Scientific Major Business
2.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.17.4 Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Boston Scientific Recent Developments and Future Plans
2.18 Arthrex
2.18.1 Arthrex Details
2.18.2 Arthrex Major Business
2.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.18.4 Arthrex Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Arthrex Recent Developments and Future Plans
2.19 Johnson & Johnson
2.19.1 Johnson & Johnson Details
2.19.2 Johnson & Johnson Major Business
2.19.3 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.19.4 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Johnson & Johnson Recent Developments and Future Plans
2.20 CSPC Pharmaceuticals
2.20.1 CSPC Pharmaceuticals Details
2.20.2 CSPC Pharmaceuticals Major Business
2.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.20.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 CSPC Pharmaceuticals Recent Developments and Future Plans
2.21 Hansoh Pharmaceuticals
2.21.1 Hansoh Pharmaceuticals Details
2.21.2 Hansoh Pharmaceuticals Major Business
2.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.21.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Hansoh Pharmaceuticals Recent Developments and Future Plans
2.22 Kelun Pharmaceuticals
2.22.1 Kelun Pharmaceuticals Details
2.22.2 Kelun Pharmaceuticals Major Business
2.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.22.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Kelun Pharmaceuticals Recent Developments and Future Plans
2.23 Zai Lab
2.23.1 Zai Lab Details
2.23.2 Zai Lab Major Business
2.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.23.4 Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Zai Lab Recent Developments and Future Plans
2.24 CStone Pharmaceuticals
2.24.1 CStone Pharmaceuticals Details
2.24.2 CStone Pharmaceuticals Major Business
2.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.24.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 CStone Pharmaceuticals Recent Developments and Future Plans
2.25 China Biopharmaceuticals
2.25.1 China Biopharmaceuticals Details
2.25.2 China Biopharmaceuticals Major Business
2.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.25.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 China Biopharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Stromal Tumor Treatment Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gastrointestinal Stromal Tumor Treatment by Company Revenue
3.2.2 Top 3 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
3.2.3 Top 6 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
3.3 Gastrointestinal Stromal Tumor Treatment Market: Overall Company Footprint Analysis
3.3.1 Gastrointestinal Stromal Tumor Treatment Market: Region Footprint
3.3.2 Gastrointestinal Stromal Tumor Treatment Market: Company Product Type Footprint
3.3.3 Gastrointestinal Stromal Tumor Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastrointestinal Stromal Tumor Treatment Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2025)
5.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
6.2 North America Gastrointestinal Stromal Tumor Treatment Market Size by Application (2020-2031)
6.3 North America Gastrointestinal Stromal Tumor Treatment Market Size by Country
6.3.1 North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
6.3.2 United States Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
6.3.3 Canada Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
6.3.4 Mexico Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
7.2 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
7.3 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country
7.3.1 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
7.3.2 Germany Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.3 France Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.5 Russia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.6 Italy Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2031)
8.3.2 China Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.3 Japan Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.4 South Korea Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.5 India Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.7 Australia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
9.2 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
9.3 South America Gastrointestinal Stromal Tumor Treatment Market Size by Country
9.3.1 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
9.3.2 Brazil Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
9.3.3 Argentina Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
10.3.2 Turkey Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10.3.4 UAE Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gastrointestinal Stromal Tumor Treatment Market Drivers
11.2 Gastrointestinal Stromal Tumor Treatment Market Restraints
11.3 Gastrointestinal Stromal Tumor Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastrointestinal Stromal Tumor Treatment Industry Chain
12.2 Gastrointestinal Stromal Tumor Treatment Upstream Analysis
12.3 Gastrointestinal Stromal Tumor Treatment Midstream Analysis
12.4 Gastrointestinal Stromal Tumor Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Gastrointestinal Stromal Tumor Treatment by Type
1.3.1 Overview: Global Gastrointestinal Stromal Tumor Treatment Market Size by Type: 2020 Versus 2024 Versus 2031
1.3.2 Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type in 2024
1.3.3 Drugs
1.3.4 Surgery Equipment
1.3.5 Others
1.4 Global Gastrointestinal Stromal Tumor Treatment Market by Application
1.4.1 Overview: Global Gastrointestinal Stromal Tumor Treatment Market Size by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Pharmacy
1.4.5 Others
1.5 Global Gastrointestinal Stromal Tumor Treatment Market Size & Forecast
1.6 Global Gastrointestinal Stromal Tumor Treatment Market Size and Forecast by Region
1.6.1 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region: 2020 VS 2024 VS 2031
1.6.2 Global Gastrointestinal Stromal Tumor Treatment Market Size by Region, (2020-2031)
1.6.3 North America Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.4 Europe Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.5 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.6 South America Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
1.6.7 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size and Prospect (2020-2031)
2 COMPANY PROFILES
2.1 B. Braun Melsungen
2.1.1 B. Braun Melsungen Details
2.1.2 B. Braun Melsungen Major Business
2.1.3 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.1.4 B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 B. Braun Melsungen Recent Developments and Future Plans
2.2 Aohua Endoscopy
2.2.1 Aohua Endoscopy Details
2.2.2 Aohua Endoscopy Major Business
2.2.3 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.2.4 Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Aohua Endoscopy Recent Developments and Future Plans
2.3 Olympus
2.3.1 Olympus Details
2.3.2 Olympus Major Business
2.3.3 Olympus Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.3.4 Olympus Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Olympus Recent Developments and Future Plans
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.4.4 Novartis Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Novartis Recent Developments and Future Plans
2.5 Bayer Pharmaceuticals
2.5.1 Bayer Pharmaceuticals Details
2.5.2 Bayer Pharmaceuticals Major Business
2.5.3 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.5.4 Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Bayer Pharmaceuticals Recent Developments and Future Plans
2.6 Glenmark Pharmaceuticals Ltd.
2.6.1 Glenmark Pharmaceuticals Ltd. Details
2.6.2 Glenmark Pharmaceuticals Ltd. Major Business
2.6.3 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.6.4 Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Glenmark Pharmaceuticals Ltd. Recent Developments and Future Plans
2.7 Fortimedix Surgical
2.7.1 Fortimedix Surgical Details
2.7.2 Fortimedix Surgical Major Business
2.7.3 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.7.4 Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Fortimedix Surgical Recent Developments and Future Plans
2.8 Cook Medical
2.8.1 Cook Medical Details
2.8.2 Cook Medical Major Business
2.8.3 Cook Medical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.8.4 Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Cook Medical Recent Developments and Future Plans
2.9 Actavis Generics
2.9.1 Actavis Generics Details
2.9.2 Actavis Generics Major Business
2.9.3 Actavis Generics Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.9.4 Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Actavis Generics Recent Developments and Future Plans
2.10 Dr. Reddy's Laboratories
2.10.1 Dr. Reddy's Laboratories Details
2.10.2 Dr. Reddy's Laboratories Major Business
2.10.3 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.10.4 Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Dr. Reddy's Laboratories Recent Developments and Future Plans
2.11 Teva Pharmaceutical Industries Ltd.
2.11.1 Teva Pharmaceutical Industries Ltd. Details
2.11.2 Teva Pharmaceutical Industries Ltd. Major Business
2.11.3 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.11.4 Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
2.12 Sonoscape
2.12.1 Sonoscape Details
2.12.2 Sonoscape Major Business
2.12.3 Sonoscape Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.12.4 Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Sonoscape Recent Developments and Future Plans
2.13 Huger endoscopy instruments
2.13.1 Huger endoscopy instruments Details
2.13.2 Huger endoscopy instruments Major Business
2.13.3 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.13.4 Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.13.5 Huger endoscopy instruments Recent Developments and Future Plans
2.14 Bulat Pharmaceutical
2.14.1 Bulat Pharmaceutical Details
2.14.2 Bulat Pharmaceutical Major Business
2.14.3 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.14.4 Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.14.5 Bulat Pharmaceutical Recent Developments and Future Plans
2.15 MSN Laboratories
2.15.1 MSN Laboratories Details
2.15.2 MSN Laboratories Major Business
2.15.3 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.15.4 MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.15.5 MSN Laboratories Recent Developments and Future Plans
2.16 Apotex Inc.
2.16.1 Apotex Inc. Details
2.16.2 Apotex Inc. Major Business
2.16.3 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.16.4 Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.16.5 Apotex Inc. Recent Developments and Future Plans
2.17 Boston Scientific
2.17.1 Boston Scientific Details
2.17.2 Boston Scientific Major Business
2.17.3 Boston Scientific Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.17.4 Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.17.5 Boston Scientific Recent Developments and Future Plans
2.18 Arthrex
2.18.1 Arthrex Details
2.18.2 Arthrex Major Business
2.18.3 Arthrex Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.18.4 Arthrex Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.18.5 Arthrex Recent Developments and Future Plans
2.19 Johnson & Johnson
2.19.1 Johnson & Johnson Details
2.19.2 Johnson & Johnson Major Business
2.19.3 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.19.4 Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.19.5 Johnson & Johnson Recent Developments and Future Plans
2.20 CSPC Pharmaceuticals
2.20.1 CSPC Pharmaceuticals Details
2.20.2 CSPC Pharmaceuticals Major Business
2.20.3 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.20.4 CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.20.5 CSPC Pharmaceuticals Recent Developments and Future Plans
2.21 Hansoh Pharmaceuticals
2.21.1 Hansoh Pharmaceuticals Details
2.21.2 Hansoh Pharmaceuticals Major Business
2.21.3 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.21.4 Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.21.5 Hansoh Pharmaceuticals Recent Developments and Future Plans
2.22 Kelun Pharmaceuticals
2.22.1 Kelun Pharmaceuticals Details
2.22.2 Kelun Pharmaceuticals Major Business
2.22.3 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.22.4 Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.22.5 Kelun Pharmaceuticals Recent Developments and Future Plans
2.23 Zai Lab
2.23.1 Zai Lab Details
2.23.2 Zai Lab Major Business
2.23.3 Zai Lab Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.23.4 Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.23.5 Zai Lab Recent Developments and Future Plans
2.24 CStone Pharmaceuticals
2.24.1 CStone Pharmaceuticals Details
2.24.2 CStone Pharmaceuticals Major Business
2.24.3 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.24.4 CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.24.5 CStone Pharmaceuticals Recent Developments and Future Plans
2.25 China Biopharmaceuticals
2.25.1 China Biopharmaceuticals Details
2.25.2 China Biopharmaceuticals Major Business
2.25.3 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
2.25.4 China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue, Gross Margin and Market Share (2020-2025)
2.25.5 China Biopharmaceuticals Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Gastrointestinal Stromal Tumor Treatment Revenue and Share by Players (2020-2025)
3.2 Market Share Analysis (2024)
3.2.1 Market Share of Gastrointestinal Stromal Tumor Treatment by Company Revenue
3.2.2 Top 3 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
3.2.3 Top 6 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
3.3 Gastrointestinal Stromal Tumor Treatment Market: Overall Company Footprint Analysis
3.3.1 Gastrointestinal Stromal Tumor Treatment Market: Region Footprint
3.3.2 Gastrointestinal Stromal Tumor Treatment Market: Company Product Type Footprint
3.3.3 Gastrointestinal Stromal Tumor Treatment Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Gastrointestinal Stromal Tumor Treatment Consumption Value and Market Share by Type (2020-2025)
4.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Type (2026-2031)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2025)
5.2 Global Gastrointestinal Stromal Tumor Treatment Market Forecast by Application (2026-2031)
6 NORTH AMERICA
6.1 North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
6.2 North America Gastrointestinal Stromal Tumor Treatment Market Size by Application (2020-2031)
6.3 North America Gastrointestinal Stromal Tumor Treatment Market Size by Country
6.3.1 North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
6.3.2 United States Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
6.3.3 Canada Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
6.3.4 Mexico Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
7.2 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
7.3 Europe Gastrointestinal Stromal Tumor Treatment Market Size by Country
7.3.1 Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
7.3.2 Germany Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.3 France Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.4 United Kingdom Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.5 Russia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
7.3.6 Italy Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8 ASIA-PACIFIC
8.1 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
8.2 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
8.3 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Market Size by Region
8.3.1 Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2031)
8.3.2 China Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.3 Japan Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.4 South Korea Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.5 India Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.6 Southeast Asia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
8.3.7 Australia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
9 SOUTH AMERICA
9.1 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
9.2 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
9.3 South America Gastrointestinal Stromal Tumor Treatment Market Size by Country
9.3.1 South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
9.3.2 Brazil Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
9.3.3 Argentina Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2031)
10.2 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2031)
10.3 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Market Size by Country
10.3.1 Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2031)
10.3.2 Turkey Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10.3.3 Saudi Arabia Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
10.3.4 UAE Gastrointestinal Stromal Tumor Treatment Market Size and Forecast (2020-2031)
11 MARKET DYNAMICS
11.1 Gastrointestinal Stromal Tumor Treatment Market Drivers
11.2 Gastrointestinal Stromal Tumor Treatment Market Restraints
11.3 Gastrointestinal Stromal Tumor Treatment Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Gastrointestinal Stromal Tumor Treatment Industry Chain
12.2 Gastrointestinal Stromal Tumor Treatment Upstream Analysis
12.3 Gastrointestinal Stromal Tumor Treatment Midstream Analysis
12.4 Gastrointestinal Stromal Tumor Treatment Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 5. B. Braun Melsungen Company Information, Head Office, and Major Competitors
Table 6. B. Braun Melsungen Major Business
Table 7. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 8. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. B. Braun Melsungen Recent Developments and Future Plans
Table 10. Aohua Endoscopy Company Information, Head Office, and Major Competitors
Table 11. Aohua Endoscopy Major Business
Table 12. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 13. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Aohua Endoscopy Recent Developments and Future Plans
Table 15. Olympus Company Information, Head Office, and Major Competitors
Table 16. Olympus Major Business
Table 17. Olympus Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 18. Olympus Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Novartis Company Information, Head Office, and Major Competitors
Table 20. Novartis Major Business
Table 21. Novartis Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 22. Novartis Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Novartis Recent Developments and Future Plans
Table 24. Bayer Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 25. Bayer Pharmaceuticals Major Business
Table 26. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 27. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Bayer Pharmaceuticals Recent Developments and Future Plans
Table 29. Glenmark Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 30. Glenmark Pharmaceuticals Ltd. Major Business
Table 31. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 32. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Glenmark Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 34. Fortimedix Surgical Company Information, Head Office, and Major Competitors
Table 35. Fortimedix Surgical Major Business
Table 36. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 37. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Fortimedix Surgical Recent Developments and Future Plans
Table 39. Cook Medical Company Information, Head Office, and Major Competitors
Table 40. Cook Medical Major Business
Table 41. Cook Medical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 42. Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Cook Medical Recent Developments and Future Plans
Table 44. Actavis Generics Company Information, Head Office, and Major Competitors
Table 45. Actavis Generics Major Business
Table 46. Actavis Generics Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 47. Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Actavis Generics Recent Developments and Future Plans
Table 49. Dr. Reddy's Laboratories Company Information, Head Office, and Major Competitors
Table 50. Dr. Reddy's Laboratories Major Business
Table 51. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 52. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Dr. Reddy's Laboratories Recent Developments and Future Plans
Table 54. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 55. Teva Pharmaceutical Industries Ltd. Major Business
Table 56. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 57. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 59. Sonoscape Company Information, Head Office, and Major Competitors
Table 60. Sonoscape Major Business
Table 61. Sonoscape Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 62. Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Sonoscape Recent Developments and Future Plans
Table 64. Huger endoscopy instruments Company Information, Head Office, and Major Competitors
Table 65. Huger endoscopy instruments Major Business
Table 66. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 67. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Huger endoscopy instruments Recent Developments and Future Plans
Table 69. Bulat Pharmaceutical Company Information, Head Office, and Major Competitors
Table 70. Bulat Pharmaceutical Major Business
Table 71. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 72. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Bulat Pharmaceutical Recent Developments and Future Plans
Table 74. MSN Laboratories Company Information, Head Office, and Major Competitors
Table 75. MSN Laboratories Major Business
Table 76. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 77. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. MSN Laboratories Recent Developments and Future Plans
Table 79. Apotex Inc. Company Information, Head Office, and Major Competitors
Table 80. Apotex Inc. Major Business
Table 81. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 82. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Apotex Inc. Recent Developments and Future Plans
Table 84. Boston Scientific Company Information, Head Office, and Major Competitors
Table 85. Boston Scientific Major Business
Table 86. Boston Scientific Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 87. Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Boston Scientific Recent Developments and Future Plans
Table 89. Arthrex Company Information, Head Office, and Major Competitors
Table 90. Arthrex Major Business
Table 91. Arthrex Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 92. Arthrex Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Arthrex Recent Developments and Future Plans
Table 94. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 95. Johnson & Johnson Major Business
Table 96. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 97. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Johnson & Johnson Recent Developments and Future Plans
Table 99. CSPC Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 100. CSPC Pharmaceuticals Major Business
Table 101. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 102. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. CSPC Pharmaceuticals Recent Developments and Future Plans
Table 104. Hansoh Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 105. Hansoh Pharmaceuticals Major Business
Table 106. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 107. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Hansoh Pharmaceuticals Recent Developments and Future Plans
Table 109. Kelun Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 110. Kelun Pharmaceuticals Major Business
Table 111. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 112. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Kelun Pharmaceuticals Recent Developments and Future Plans
Table 114. Zai Lab Company Information, Head Office, and Major Competitors
Table 115. Zai Lab Major Business
Table 116. Zai Lab Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 117. Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. Zai Lab Recent Developments and Future Plans
Table 119. CStone Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 120. CStone Pharmaceuticals Major Business
Table 121. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 122. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. CStone Pharmaceuticals Recent Developments and Future Plans
Table 124. China Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 125. China Biopharmaceuticals Major Business
Table 126. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 127. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. China Biopharmaceuticals Recent Developments and Future Plans
Table 129. Global Gastrointestinal Stromal Tumor Treatment Revenue (USD Million) by Players (2020-2025)
Table 130. Global Gastrointestinal Stromal Tumor Treatment Revenue Share by Players (2020-2025)
Table 131. Breakdown of Gastrointestinal Stromal Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 132. Market Position of Players in Gastrointestinal Stromal Tumor Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 133. Head Office of Key Gastrointestinal Stromal Tumor Treatment Players
Table 134. Gastrointestinal Stromal Tumor Treatment Market: Company Product Type Footprint
Table 135. Gastrointestinal Stromal Tumor Treatment Market: Company Product Application Footprint
Table 136. Gastrointestinal Stromal Tumor Treatment New Market Entrants and Barriers to Market Entry
Table 137. Gastrointestinal Stromal Tumor Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 138. Global Gastrointestinal Stromal Tumor Treatment Consumption Value (USD Million) by Type (2020-2025)
Table 139. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Type (2020-2025)
Table 140. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Forecast by Type (2026-2031)
Table 141. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025)
Table 142. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Forecast by Application (2026-2031)
Table 143. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 144. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 145. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 146. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 147. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 150. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 151. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 152. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 153. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 154. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 155. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 156. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 157. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 160. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 161. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 162. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 163. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 164. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 165. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 166. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 167. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 168. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 169. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 170. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 171. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 172. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Global Key Players of Gastrointestinal Stromal Tumor Treatment Upstream (Raw Materials)
Table 174. Global Gastrointestinal Stromal Tumor Treatment Typical Customers
Table 1. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 4. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 5. B. Braun Melsungen Company Information, Head Office, and Major Competitors
Table 6. B. Braun Melsungen Major Business
Table 7. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 8. B. Braun Melsungen Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 9. B. Braun Melsungen Recent Developments and Future Plans
Table 10. Aohua Endoscopy Company Information, Head Office, and Major Competitors
Table 11. Aohua Endoscopy Major Business
Table 12. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 13. Aohua Endoscopy Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 14. Aohua Endoscopy Recent Developments and Future Plans
Table 15. Olympus Company Information, Head Office, and Major Competitors
Table 16. Olympus Major Business
Table 17. Olympus Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 18. Olympus Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 19. Novartis Company Information, Head Office, and Major Competitors
Table 20. Novartis Major Business
Table 21. Novartis Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 22. Novartis Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 23. Novartis Recent Developments and Future Plans
Table 24. Bayer Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 25. Bayer Pharmaceuticals Major Business
Table 26. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 27. Bayer Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 28. Bayer Pharmaceuticals Recent Developments and Future Plans
Table 29. Glenmark Pharmaceuticals Ltd. Company Information, Head Office, and Major Competitors
Table 30. Glenmark Pharmaceuticals Ltd. Major Business
Table 31. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 32. Glenmark Pharmaceuticals Ltd. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 33. Glenmark Pharmaceuticals Ltd. Recent Developments and Future Plans
Table 34. Fortimedix Surgical Company Information, Head Office, and Major Competitors
Table 35. Fortimedix Surgical Major Business
Table 36. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 37. Fortimedix Surgical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 38. Fortimedix Surgical Recent Developments and Future Plans
Table 39. Cook Medical Company Information, Head Office, and Major Competitors
Table 40. Cook Medical Major Business
Table 41. Cook Medical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 42. Cook Medical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 43. Cook Medical Recent Developments and Future Plans
Table 44. Actavis Generics Company Information, Head Office, and Major Competitors
Table 45. Actavis Generics Major Business
Table 46. Actavis Generics Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 47. Actavis Generics Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 48. Actavis Generics Recent Developments and Future Plans
Table 49. Dr. Reddy's Laboratories Company Information, Head Office, and Major Competitors
Table 50. Dr. Reddy's Laboratories Major Business
Table 51. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 52. Dr. Reddy's Laboratories Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 53. Dr. Reddy's Laboratories Recent Developments and Future Plans
Table 54. Teva Pharmaceutical Industries Ltd. Company Information, Head Office, and Major Competitors
Table 55. Teva Pharmaceutical Industries Ltd. Major Business
Table 56. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 57. Teva Pharmaceutical Industries Ltd. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 58. Teva Pharmaceutical Industries Ltd. Recent Developments and Future Plans
Table 59. Sonoscape Company Information, Head Office, and Major Competitors
Table 60. Sonoscape Major Business
Table 61. Sonoscape Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 62. Sonoscape Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 63. Sonoscape Recent Developments and Future Plans
Table 64. Huger endoscopy instruments Company Information, Head Office, and Major Competitors
Table 65. Huger endoscopy instruments Major Business
Table 66. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 67. Huger endoscopy instruments Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 68. Huger endoscopy instruments Recent Developments and Future Plans
Table 69. Bulat Pharmaceutical Company Information, Head Office, and Major Competitors
Table 70. Bulat Pharmaceutical Major Business
Table 71. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 72. Bulat Pharmaceutical Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 73. Bulat Pharmaceutical Recent Developments and Future Plans
Table 74. MSN Laboratories Company Information, Head Office, and Major Competitors
Table 75. MSN Laboratories Major Business
Table 76. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 77. MSN Laboratories Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 78. MSN Laboratories Recent Developments and Future Plans
Table 79. Apotex Inc. Company Information, Head Office, and Major Competitors
Table 80. Apotex Inc. Major Business
Table 81. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 82. Apotex Inc. Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 83. Apotex Inc. Recent Developments and Future Plans
Table 84. Boston Scientific Company Information, Head Office, and Major Competitors
Table 85. Boston Scientific Major Business
Table 86. Boston Scientific Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 87. Boston Scientific Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 88. Boston Scientific Recent Developments and Future Plans
Table 89. Arthrex Company Information, Head Office, and Major Competitors
Table 90. Arthrex Major Business
Table 91. Arthrex Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 92. Arthrex Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 93. Arthrex Recent Developments and Future Plans
Table 94. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 95. Johnson & Johnson Major Business
Table 96. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 97. Johnson & Johnson Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 98. Johnson & Johnson Recent Developments and Future Plans
Table 99. CSPC Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 100. CSPC Pharmaceuticals Major Business
Table 101. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 102. CSPC Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 103. CSPC Pharmaceuticals Recent Developments and Future Plans
Table 104. Hansoh Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 105. Hansoh Pharmaceuticals Major Business
Table 106. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 107. Hansoh Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 108. Hansoh Pharmaceuticals Recent Developments and Future Plans
Table 109. Kelun Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 110. Kelun Pharmaceuticals Major Business
Table 111. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 112. Kelun Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 113. Kelun Pharmaceuticals Recent Developments and Future Plans
Table 114. Zai Lab Company Information, Head Office, and Major Competitors
Table 115. Zai Lab Major Business
Table 116. Zai Lab Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 117. Zai Lab Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 118. Zai Lab Recent Developments and Future Plans
Table 119. CStone Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 120. CStone Pharmaceuticals Major Business
Table 121. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 122. CStone Pharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 123. CStone Pharmaceuticals Recent Developments and Future Plans
Table 124. China Biopharmaceuticals Company Information, Head Office, and Major Competitors
Table 125. China Biopharmaceuticals Major Business
Table 126. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Product and Solutions
Table 127. China Biopharmaceuticals Gastrointestinal Stromal Tumor Treatment Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 128. China Biopharmaceuticals Recent Developments and Future Plans
Table 129. Global Gastrointestinal Stromal Tumor Treatment Revenue (USD Million) by Players (2020-2025)
Table 130. Global Gastrointestinal Stromal Tumor Treatment Revenue Share by Players (2020-2025)
Table 131. Breakdown of Gastrointestinal Stromal Tumor Treatment by Company Type (Tier 1, Tier 2, and Tier 3)
Table 132. Market Position of Players in Gastrointestinal Stromal Tumor Treatment, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 133. Head Office of Key Gastrointestinal Stromal Tumor Treatment Players
Table 134. Gastrointestinal Stromal Tumor Treatment Market: Company Product Type Footprint
Table 135. Gastrointestinal Stromal Tumor Treatment Market: Company Product Application Footprint
Table 136. Gastrointestinal Stromal Tumor Treatment New Market Entrants and Barriers to Market Entry
Table 137. Gastrointestinal Stromal Tumor Treatment Mergers, Acquisition, Agreements, and Collaborations
Table 138. Global Gastrointestinal Stromal Tumor Treatment Consumption Value (USD Million) by Type (2020-2025)
Table 139. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Type (2020-2025)
Table 140. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Forecast by Type (2026-2031)
Table 141. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025)
Table 142. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Forecast by Application (2026-2031)
Table 143. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 144. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 145. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 146. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 147. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 148. North America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 149. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 150. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 151. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 152. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 153. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 154. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 155. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 156. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 157. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 158. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 159. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2020-2025) & (USD Million)
Table 160. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value by Region (2026-2031) & (USD Million)
Table 161. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 162. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 163. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 164. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 165. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 166. South America Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 167. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2020-2025) & (USD Million)
Table 168. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Type (2026-2031) & (USD Million)
Table 169. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2020-2025) & (USD Million)
Table 170. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Application (2026-2031) & (USD Million)
Table 171. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2020-2025) & (USD Million)
Table 172. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value by Country (2026-2031) & (USD Million)
Table 173. Global Key Players of Gastrointestinal Stromal Tumor Treatment Upstream (Raw Materials)
Table 174. Global Gastrointestinal Stromal Tumor Treatment Typical Customers
LIST OF FIGURES
Figure 1. Gastrointestinal Stromal Tumor Treatment Picture
Figure 2. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type in 2024
Figure 4. Drugs
Figure 5. Surgery Equipment
Figure 6. Others
Figure 7. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application in 2024
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Gastrointestinal Stromal Tumor Treatment Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Gastrointestinal Stromal Tumor Treatment Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Gastrointestinal Stromal Tumor Treatment Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region in 2024
Figure 18. North America Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Gastrointestinal Stromal Tumor Treatment Revenue Share by Players in 2024
Figure 25. Gastrointestinal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Gastrointestinal Stromal Tumor Treatment by Player Revenue in 2024
Figure 27. Top 3 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
Figure 28. Top 6 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
Figure 29. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Type (2020-2025)
Figure 30. Global Gastrointestinal Stromal Tumor Treatment Market Share Forecast by Type (2026-2031)
Figure 31. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Application (2020-2025)
Figure 32. Global Gastrointestinal Stromal Tumor Treatment Market Share Forecast by Application (2026-2031)
Figure 33. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 43. France Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region (2020-2031)
Figure 50. China Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 53. India Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 67. Gastrointestinal Stromal Tumor Treatment Market Drivers
Figure 68. Gastrointestinal Stromal Tumor Treatment Market Restraints
Figure 69. Gastrointestinal Stromal Tumor Treatment Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Gastrointestinal Stromal Tumor Treatment Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Gastrointestinal Stromal Tumor Treatment Picture
Figure 2. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type in 2024
Figure 4. Drugs
Figure 5. Surgery Equipment
Figure 6. Others
Figure 7. Global Gastrointestinal Stromal Tumor Treatment Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 8. Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application in 2024
Figure 9. Hospital Picture
Figure 10. Clinic Picture
Figure 11. Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Gastrointestinal Stromal Tumor Treatment Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 14. Global Gastrointestinal Stromal Tumor Treatment Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 15. Global Market Gastrointestinal Stromal Tumor Treatment Consumption Value (USD Million) Comparison by Region (2020 VS 2024 VS 2031)
Figure 16. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region (2020-2031)
Figure 17. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region in 2024
Figure 18. North America Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 19. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 20. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 21. South America Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 22. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 23. Company Three Recent Developments and Future Plans
Figure 24. Global Gastrointestinal Stromal Tumor Treatment Revenue Share by Players in 2024
Figure 25. Gastrointestinal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2024
Figure 26. Market Share of Gastrointestinal Stromal Tumor Treatment by Player Revenue in 2024
Figure 27. Top 3 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
Figure 28. Top 6 Gastrointestinal Stromal Tumor Treatment Players Market Share in 2024
Figure 29. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Type (2020-2025)
Figure 30. Global Gastrointestinal Stromal Tumor Treatment Market Share Forecast by Type (2026-2031)
Figure 31. Global Gastrointestinal Stromal Tumor Treatment Consumption Value Share by Application (2020-2025)
Figure 32. Global Gastrointestinal Stromal Tumor Treatment Market Share Forecast by Application (2026-2031)
Figure 33. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 34. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 35. North America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 36. United States Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 37. Canada Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 38. Mexico Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 39. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 40. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 41. Europe Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 42. Germany Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 43. France Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 44. United Kingdom Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 45. Russia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 46. Italy Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 47. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 48. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 49. Asia-Pacific Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Region (2020-2031)
Figure 50. China Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 51. Japan Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 52. South Korea Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 53. India Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 54. Southeast Asia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 55. Australia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 56. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 57. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 58. South America Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 59. Brazil Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 60. Argentina Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 61. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Type (2020-2031)
Figure 62. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Application (2020-2031)
Figure 63. Middle East & Africa Gastrointestinal Stromal Tumor Treatment Consumption Value Market Share by Country (2020-2031)
Figure 64. Turkey Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 65. Saudi Arabia Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 66. UAE Gastrointestinal Stromal Tumor Treatment Consumption Value (2020-2031) & (USD Million)
Figure 67. Gastrointestinal Stromal Tumor Treatment Market Drivers
Figure 68. Gastrointestinal Stromal Tumor Treatment Market Restraints
Figure 69. Gastrointestinal Stromal Tumor Treatment Market Trends
Figure 70. Porters Five Forces Analysis
Figure 71. Gastrointestinal Stromal Tumor Treatment Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
